Leah Soriaga and Amalio Telenti publish today work performed at Vir Biotechnology on the human host genetic landscape of The genetic underpinnings of respiratory viral infection. This is a landmark study of the network of genes supporting infection of 9 human respiratory viruses: influenza, parainfluenza virus, rhinovirus, RSV, common human coronavirus, MERS and SARS-CoV-2. Link: https://www.pnas.org/doi/epub/10.1073/pnas.2414202122

Leah Soriaga joins Trail as head of bioinformatics, and Zita Rovó joins as head of product. Welcome to the growing team!

Trail Biomed is awarded a grant of over $2.65million from the Gates Foundation. Trail Biomed, a Swiss company founded by AmalioTelenti, aims at advancing global health through innovative therapeutics. This funding will support the development of a working framework for data interoperability and validation, integrating wet bench data generation with AI tools to create novel, cost-effective small molecule therapies to improve public health.This initiative represents a significant step toward addressing critical gaps in data integration and fostering rapid testing and validation of drug leads. For more information, visit trail biomed.